---
$id: https://graph.org.ai/products/commodity/51203302
$type: Product
source: UNSPSC
code: "51203302"
title: "Fingolimod"
class: "51203300"
classTitle: "Immunosupressant phthalimides"
family: "51200000"
familyTitle: "Immunomodulating drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Fingolimod

**UNSPSC Code**: 51203302
**Class**: [Immunosupressant phthalimides](Immunosupressant phthalimides.mdx)
**Family**: [Immunomodulating drugs](../Immunomodulating drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a biological response modifier, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 3QN8BYN5QF. European Medicines Agency schedules Fingolimod in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB31908. Fingolimod generally arises in the molecular formula C19H33NO2. The term FINGOLIMOD is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19, No. 1, 2005, list 53.) Most nations, for tariff and trade purposes, schedule fingolimod under HS 29221980 and SITC 51461. As of Q4 2014, FINGOLIMOD remains US FDA's Preferred Term for this commodity. Fingolimod bears US NLM identifiers UMLS ID C1699926 and NCI Concept Code C74202. SMILES: CCCCCCCCC1=CC=C(C=C1)CCC(CO)(CO)N.

